Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)

Author:

Pinós Tomàs,Andreu Antoni L.,Bruno Claudio,Hadjigeorgiou Georgios M.,Haller Ronald G.,Laforêt Pascal,Lucía Alejandro,Martín Miguel A.,Martinuzzi Andrea,Navarro Carmen,Oflazer Piraye,Pouget Jean,Quinlivan Ros,Sacconi Sabrina,Scalco Renata S.,Toscano Antonio,Vissing John,Vorgerd Matthias,Wakelin Andrew,Martí RamonORCID,Andreu Antoni L.,Martí Ramon,Pinós Tomàs,Baruch Noemi,Ortega Francisco J.,Martín Miguel A.,Navarro Carmen,San-Millán Beatriz,Vieitez Irene,Martinuzzi Andrea,Vavla Marinela,Bruno Claudio,Toscano Antonio,Musumeci Olimpia,Laforêt Pascal,Sacconi Sabrina,Quinlivan Ros,Scalco Renata,Wakelin Andrew,Hadjgeorgiou Georgios,Zintzaras Elias,Vissing John,Vorgerd Matthias,Zülow Enrico,Haller Ronald,Oflazer Piraye,Durmus Hacer,Pouget Jean,Lucía Alejandro,Santalla Alfredo,

Abstract

Abstract Background International patient registries are of particular importance for rare disorders, as they may contribute to overcome the lack of knowledge derived from low number of patients and limited awareness of these diseases, and help to learn more about their geographical or population-based specificities, which is relevant for research purposes and for promoting better standards of care and diagnosis. Our objective was to create and implement a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC) and to disseminate the knowledge of these disorders. Results Teams from nine different countries (United Kingdom, Spain, Italy, France, Germany, Denmark, Greece, Turkey and USA) created a consortium that developed the first European registry dedicated to rare muscle glycogenoses. A work plan was implemented to design the database and platform that constitute the registry, by choosing clinical, genetics and molecular variables of interest, based on experience gained from previous national registries for similar metabolic disorders. Among dissemination activities, several teaching events were organized in different countries, especially those where the consortium considered the awareness of these diseases needs to be promoted among health professionals and patients. Conclusion EUROMAC represents a step forward in the knowledge of those disorders to which it is dedicated, and will have relevant clinical outcomes at the diagnostic, epidemiological, clinical and research level.

Funder

Consumers, Health and Food Executive Agency

Instituto de Salud Carlos III

CIBERER

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3